Delivery Order SPE2DB20D1004-SPE2DB23FF1S5
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Insulin Lispro 100 Unit/mL vials, a pharmaceutical product used for the management of diabetes. The contract was awarded on August 9, 2021, with a ceiling value of $2,283.98 and a completion date of August 10, 2021. The contract is a Delivery Order, with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,410.24 delivery order contract is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, a critical medication for diabetes management. The contract has an ultimate completion date of October 24, 2022 and is a firm fixed-price delivery order. This award is associated with AmerisourceBergen's larger $999,999,999...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,275.48, is for the delivery of Insulin Lispro 100 Unit/mL Vials (10 mL) to support military healthcare programs. The contract has a firm fixed price and a completion date of July 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,553.84 Firm Fixed Price Delivery Order is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, a critical diabetes management medication. The contract has an ultimate completion date of August 22, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FH7V1) valued at $2,757.73 for the supply of Insulin Lispro 100 Unit/mL. The contract was awarded on February 10, 2022, with a completion date of February 11, 2022, by the Defense Logistics Agency (DLA), a defense agency. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,565.17 Firm Fixed Price contract is for the delivery of Insulin Lispro 100 Unit/mL Vial 10mL, a critical pharmaceutical product. The contract has an ultimate completion date of June 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,343.00 Firm Fixed Price Delivery Order is for the supply of 4565826728 units of Insulin Lispro 100 Unit/mL Pen 3mL, with a completion date of September 17, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,647.52 delivery order is for the supply of insulin lispro medication in 3 mL pen format, with a completion date of December 8, 2021. The contract has a firm fixed price pricing type and does not utilize any set-aside requirements, indicating full and open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,423.95 Firm Fixed Price Delivery Order is for the supply of 10 mL vials of insulin aspart 100 unit/mL. The contract has an ultimate completion date of January 26, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which serves as a critical supplier of pharmaceutical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $7,679.51 firm fixed price delivery order is for the supply of 10 mL vials of Insulin Aspart 100 unit/mL, a critical medication for the management of diabetes. The contract has an ultimate completion date of October 21, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a significant...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB23FF1S5Delivery Order
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,324.68 firm-fixed-price contract is for the supply of Insulin Lispro 100 Unit/mL vials, a critical medication for diabetes management. The contract has an ultimate completion date of February 6, 2023. Amerisourcebergen Drug Corp is a significant supplier of pharmaceutical products and medical supplies to the federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for delivering a comprehensive range of essential medications and medical commodities to support military and veteran healthcare needs globally. This delivery order is issued under that larger IDC contract. There is no set-aside designation for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 2/3/23 |